These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2571888)

  • 1. Increased brain 3-hydroxykynurenine in Huntington's disease.
    Reynolds GP; Pearson SJ
    Lancet; 1989 Oct; 2(8669):979-80. PubMed ID: 2571888
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased brain concentrations of a neurotoxin, 3-hydroxykynurenine, in Huntington's disease.
    Pearson SJ; Reynolds GP
    Neurosci Lett; 1992 Sep; 144(1-2):199-201. PubMed ID: 1436703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tryptophan metabolism and oxidative stress in patients with Huntington's disease.
    Stoy N; Mackay GM; Forrest CM; Christofides J; Egerton M; Stone TW; Darlington LG
    J Neurochem; 2005 May; 93(3):611-23. PubMed ID: 15836620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical studies in Huntington's chorea. VII. The lipid composition of the cerebral white and gray matter.
    Hooghwinkel GJ; Bruyn GW; de Rooy RE
    Neurology; 1968 Apr; 18(4):408-12. PubMed ID: 4232362
    [No Abstract]   [Full Text] [Related]  

  • 5. An investigation of the activities of 3-hydroxykynureninase and kynurenine aminotransferase in the brain in Huntington's disease.
    Pearson SJ; Meldrum A; Reynolds GP
    J Neural Transm Gen Sect; 1995; 102(1):67-73. PubMed ID: 8785025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysfunctional kynurenine pathway metabolism in the R6/2 mouse model of Huntington's disease.
    Sathyasaikumar KV; Stachowski EK; Amori L; Guidetti P; Muchowski PJ; Schwarcz R
    J Neurochem; 2010 Jun; 113(6):1416-25. PubMed ID: 20236387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tryptophan metabolites and brain disorders.
    Stone TW; Mackay GM; Forrest CM; Clark CJ; Darlington LG
    Clin Chem Lab Med; 2003 Jul; 41(7):852-9. PubMed ID: 12940508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased proteins in post-mortem brain in a case of Pick's disease and in Huntington's disease.
    Borthwick NM; Gordon A; Yates CM
    J Neurol Sci; 1985 Dec; 71(2-3):377-86. PubMed ID: 2935597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurochemical-clinical correlates in Huntington's disease--applications of brain banking techniques.
    Reynolds GP; Pearson SJ
    J Neural Transm Suppl; 1993; 39():207-14. PubMed ID: 8103075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postmortem studies of peptides in Alzheimer's disease and Huntington's disease.
    Rossor M; Emson P; Dawbarn D; Dockray G; Mountjoy C; Roth M
    Res Publ Assoc Res Nerv Ment Dis; 1986; 64():259-77. PubMed ID: 2425405
    [No Abstract]   [Full Text] [Related]  

  • 11. Is 3-hydroxykynurenine an endogenous neurotoxin in Huntington's disease?
    Guilarte TR; Eastman CL
    J Neurol Sci; 1993 Jun; 116(2):227-8. PubMed ID: 8336170
    [No Abstract]   [Full Text] [Related]  

  • 12. Elevated brain 3-hydroxykynurenine and quinolinate levels in Huntington disease mice.
    Guidetti P; Bates GP; Graham RK; Hayden MR; Leavitt BR; MacDonald ME; Slow EJ; Wheeler VC; Woodman B; Schwarcz R
    Neurobiol Dis; 2006 Jul; 23(1):190-7. PubMed ID: 16697652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neostriatal and cortical quinolinate levels are increased in early grade Huntington's disease.
    Guidetti P; Luthi-Carter RE; Augood SJ; Schwarcz R
    Neurobiol Dis; 2004 Dec; 17(3):455-61. PubMed ID: 15571981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tryptophan loading test in Huntington's chorea].
    Oepen I; Oepen H
    Humangenetik; 1969; 7(3):197-202. PubMed ID: 4240656
    [No Abstract]   [Full Text] [Related]  

  • 15. Positive identification of kynurenine in rat and human brain [proceedings].
    Joseph MH; Baker HF; Lawson AM
    Biochem Soc Trans; 1978; 6(1):123-6. PubMed ID: 640137
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma choline and cholinergic mechanisms in the brain. Methods, function, and rôle in Huntington's chorea.
    Eckernäs SA
    Acta Physiol Scand Suppl; 1977; 449():1-62. PubMed ID: 143869
    [No Abstract]   [Full Text] [Related]  

  • 17. Brain GABA levels in asymptomatic Huntington's disease.
    Reynolds GP; Pearson SJ
    N Engl J Med; 1990 Sep; 323(10):682. PubMed ID: 2143559
    [No Abstract]   [Full Text] [Related]  

  • 18. Involvement of kynurenines in Huntington's disease and stroke-induced brain damage.
    Stone TW; Forrest CM; Stoy N; Darlington LG
    J Neural Transm (Vienna); 2012 Feb; 119(2):261-74. PubMed ID: 21695417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Huntington's disease--review on neuroscientific approaches].
    Kanazawa I
    Tanpakushitsu Kakusan Koso; 1984 Dec; 29(14):1815-25. PubMed ID: 6241961
    [No Abstract]   [Full Text] [Related]  

  • 20. The kynurenine pathway in neurodegenerative diseases: mechanistic and therapeutic considerations.
    Tan L; Yu JT; Tan L
    J Neurol Sci; 2012 Dec; 323(1-2):1-8. PubMed ID: 22939820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.